After DES DiEthylStilbestrol : tracking the Harms of a Prenatal Drug Exposure

NCI Cancer Bulletin Archives 2011

After DES: Tracking the Harms of a Prenatal Drug Exposure
NCI Cancer Bulletin for October 18, 2011

Kari Christianson was 23 years old when she first heard of a drug called diethylstilbestrol, or DES.

It was the spring of 1972, and Dr. Arthur Herbst – who had recently published the study Adenocarcinoma of the Vagina — Association of Maternal Stilbestrol Therapy with Tumor Appearance in Young Women  suggesting that the drug, when used by pregnant women, might cause cancer in their offspring years later – was on television discussing concerns about the drug. For decades, doctors had prescribed DES to millions of healthy pregnant women, including Kari’s mother, based on unsubstantiated claims that it reduced the complications of pregnancy. “

Continue reading Kari’s story and Edward Winstead‘s post:
After DES: Tracking the Harms of a Prenatal Drug Exposure
NCI Cancer Bulletin for October 18, 2011.

More DES DiEthylStilbestrol Resources

2 thoughts on “After DES DiEthylStilbestrol : tracking the Harms of a Prenatal Drug Exposure”

  1. Are there currently any clinical studies going on that we can participate in?

Have your say ! Share your views